LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

Kodu・Aktsiate loetelu・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Suletud

1.58 1.94

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.53

Max

1.5899999999999999

Põhinäitajad
By Trading Economics
Sissetulek	17M -26M
Aktsiakasum	-0.43
Kasumimarginaal	-2,190.837
Töötajad	171
EBITDA	19M -23M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+93.55% upside

Turustatistika
By TradingEconomics
Turukapital	-1.1M 101M
Eelmine avamishind	-0.36
Eelmine sulgemishind	1.58

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

1.43 / 1.6 Toetus ja vastupanu

Pliant Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. nov 2025, 21:54 UTC

Omandamised, ülevõtmised, äriostud

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

24. nov 2025, 18:26 UTC

Suurimad hinnamuutused turgudel

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

24. nov 2025, 23:49 UTC

Market Talk

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

24. nov 2025, 23:08 UTC

Market Talk

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

24. nov 2025, 23:08 UTC

Market Talk

Global Equities Roundup: Market Talk

24. nov 2025, 22:56 UTC

Market Talk

Tulu

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

24. nov 2025, 22:47 UTC

Market Talk

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

24. nov 2025, 22:36 UTC

Market Talk

Tulu

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

24. nov 2025, 22:32 UTC

Tulu

Webco Industries 1Q EPS $6.79 >WEBC

24. nov 2025, 22:07 UTC

Tulu

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

24. nov 2025, 22:07 UTC

Tulu

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q Adj EPS 78c >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q Rev $17.9B >ATD.T

24. nov 2025, 22:06 UTC

Tulu

Couche-Tard 2Q EPS 79c >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Rev $17.9B >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Net $740.6M >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q Adj EPS 78c >ATD.T

24. nov 2025, 22:05 UTC

Tulu

Couche-Tard 2Q EPS 79c >ATD.T

24. nov 2025, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

24. nov 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

24. nov 2025, 21:44 UTC

Market Talk

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

24. nov 2025, 21:39 UTC

Omandamised, ülevõtmised, äriostud

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

24. nov 2025, 20:42 UTC

Market Talk

Oil Futures Snap Three-Session Losing Streak -- Market Talk

24. nov 2025, 20:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

24. nov 2025, 19:56 UTC

Omandamised, ülevõtmised, äriostud

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

24. nov 2025, 18:26 UTC

Market Talk

Crude Futures Move Higher in Choppy Trade -- Market Talk

24. nov 2025, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

24. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

24. nov 2025, 17:09 UTC

Market Talk

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

24. nov 2025, 16:52 UTC

Omandamised, ülevõtmised, äriostud

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Pliant Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

93.55% tõus

12 kuu keskmine prognoos

Keskmine 3 USD 93.55%

Kõrge 4 USD

Madal 2 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Pliant Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Pliant Therapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

1.43 / 1.6Toetus ja vastupanu

Recent bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.